LEP and neoplasm: One possible explanation is that Ob-R overexpression in tumor cells might activate the leptin-Ob-R-JAK2/STAT3 axis as well as other pathways such as PI3K/AKT and MAPK producing a proliferative stage through which is more sensitive to chemotherapy.